All lobbying filings

AXADVOCACY GOVERNMENT RELATIONS

Lobbying for IMMIX BIOPHARMA INC. · Clinical-stage biopharmaceutical company developing next-generation CAR-T cell therapies.

Filing Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 4

JEFFREY BILLMAN New on this filing

Previously held: Chief of Staff, Rep. Ronny Jackson; Dep. Chief of Staff, Rep. Kevin Brady; Dep. Chief of Staff, Rep. Kevin Hern; Dep. Chief of Staff, Rep. Peter Roskam; Legis. Asst., Rep. Peter Roskam; Spec. Asst. to Chief Dep. Whip Peter Roskam
ROBERT BABCOCK JR New on this filing

Previously held: Senior Legislative Assistant/Legislative Assistant, Congressman Steve King; Legislative Aide/Legislative Correspondent/Staff Assistant, Senator Kay Bailey Hutchison; Regional Administrator, GSA Greater Southwest Region
ELLE WESTRA New on this filing

Previously held: Intern, Senator John Thune; Staff Assistant, Senator John Thune
ARTHUR WARREN SCOTT New on this filing

Previously held: Staff Assistant, Senator Cornyn; Intern, Senator Cornyn; Intern, Senator Wicker

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to FDA drug approval processes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.